Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and immune cells. The company's lead product is KORSUVA (difelikefalin) injection for the treatment of moderate-to-severe pruritus associated with chronic kidney disease (CKD) in adults undergoing hemodialysis. Its product candidate includes Oral KORSUVA (difelikefalin), which has completed Phase II clinical trial to treat pruritus atopic dermatitis and pruritus non-dialysis-dependent chronic kidney disease (NDD-CKD) associated pruritus; and in Phase II clinical trial to treat pruritus chronic liver disease (CLD) primary biliary cholangitis (PBC) and notalgia paresthetica. The company has license agreements with Maruishi Pharmaceutical Co., Ltd to develop, manufacture, and commercialize drug products containing difelikefalin for acute pain and uremic pruritus in Japan; and Chong Kun Dang Pharmaceutical Corporation to develop, manufacture, and commercialize drug products containing difelikefalin in South Korea. Cara Therapeutics, Inc. was incorporated in 2004 and is based in Stamford, Connecticut. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Cara Therapeutics Inc..
Cara Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Cara Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Cara Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Cara Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Cara Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Cara Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Cara Therapeutics Inc.- Key Facts
2.2 Cara Therapeutics Inc.- Geographic Locations
2.3 Cara Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Cara Therapeutics Inc.- Business Divisions
2.5 Cara Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Cara Therapeutics Inc. Strategic Analysis Review
3.1 Cara Therapeutics Inc.- Key Strategies
3.2 Cara Therapeutics Inc.- Company Outlook Statement
3.3 Cara Therapeutics Inc.- SWOT Analysis
3.3.1 Cara Therapeutics Inc.- Key Strengths
3.3.2 Cara Therapeutics Inc.- Key Weaknesses
3.3.3 Cara Therapeutics Inc.- Potential Opportunities
3.3.4 Cara Therapeutics Inc.- Potential Threats
3.4 Cara Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Cara Therapeutics Inc.- Business Overview
4.2 Cara Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Cara Therapeutics Inc.- Key Products
5.2 Cara Therapeutics Inc.- Key Service Areas
5.3 Cara Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Cara Therapeutics Inc.- Company History
6.2 Cara Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Cara Therapeutics Inc.- Income Statements
7.2 Cara Therapeutics Inc.- Balance Sheet
7.3 Cara Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Cara Therapeutics Inc.- Direct Competitors
8.2 Cara Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Cara Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Cara Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
$50- 50%
$100- 30%
$200- 30%
$100- 30%
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!